Episode 510: ADCs in Prostate Cancer
From The Uromigos · · 30 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Tanya Dorff joins Tom and Brian to discuss her ASCO 2026 data on a novel dual targeting ADC in prostate cancer. The broader scope of ADC development in prostate cancer is discussed with a focus on cytopenia toxicity and future direcctions.